Maternal immunization: US FDA regulatory considerations.
about
Prevention strategies for herpes zoster and post-herpetic neuralgiaPertussis vaccination for adolescents and adults.A global survey of adverse event following immunization surveillance systems for pregnant women and their infantsSafety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review.Adverse event following immunization surveillance systems for pregnant women and their infants: a systematic review.
P2860
Maternal immunization: US FDA regulatory considerations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Maternal immunization: US FDA regulatory considerations.
@ast
Maternal immunization: US FDA regulatory considerations.
@en
type
label
Maternal immunization: US FDA regulatory considerations.
@ast
Maternal immunization: US FDA regulatory considerations.
@en
prefLabel
Maternal immunization: US FDA regulatory considerations.
@ast
Maternal immunization: US FDA regulatory considerations.
@en
P1433
P1476
Maternal immunization: US FDA regulatory considerations.
@en
P2093
Marion F Gruber
P304
P356
10.1016/S0264-410X(03)00357-8
P407
P577
2003-07-01T00:00:00Z